However, omeprazole's enteric-coated formulation is designed to protect it from stomach acid and allow absorption in the small intestine, which helps mitigate potential absorption issues related to delayed gastric emptying
A large real-world study suggests semaglutide's cardiovascular benefits may be more closely linked to the dose patients receive than to the amount of weight they lose, offering new insight into how the drug may protect heart health
The side effects settled down around week ten, and now I barely notice anything except the weekly injection routine
These are the six things you need to know about how the new Wegovy pill compares to the Wegovy shot
The negotiation trigger timeline: small molecules become eligible 9 years after first approval
Note: Medicare Part D excludes weight loss coverage, but the new Medicare GLP-1 Bridge (July 2026) will cover Zepbound KwikPen at $50/month for qualifying beneficiaries